| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 01/17/2007 | EP1742944A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/17/2007 | EP1742905A2 Process of making alfa-aminooxyketone/ alfa-aminooxyaldehyde and alfa-hydroxyketone/ alfa-hydroxyaldehyde compounds and a process of making reaction products from cyclic alfa, beta-unsaturated ketone substrates and nitroso substrates |
| 01/17/2007 | EP1546369A4 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | EP1070068B2 Granulatimide derivatives for use in cancer treatment |
| 01/17/2007 | CN1898247A Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/17/2007 | CN1898238A Oxazolidinone-quinolone hybrid antibiotics |
| 01/17/2007 | CN1898212A Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
| 01/16/2007 | US7164021 Intensify therapy of analgesics; immunology diseases; antiinflammatory agents; drug abuse; diarrhea; cardiovascular disorders; antisecretory agents; respiratory system disorders |
| 01/16/2007 | US7164017 Exhibit electrophysiological activity |
| 01/16/2007 | US7163947 1-Amino 1H-imidazoquinolines |
| 01/16/2007 | US7163939 important in the progression of many disease states that are induced by the inappropriate proliferation of cells; anticancer agent |
| 01/16/2007 | CA2254755C Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs |
| 01/16/2007 | CA2111372C Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists |
| 01/11/2007 | WO2007005403A1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands |
| 01/11/2007 | WO2007004688A1 Xanthine oxidase inhibitor |
| 01/11/2007 | CA2613428A1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands |
| 01/10/2007 | EP1740710A1 Labeling of rapamycin using rapamycin-specific methylases |
| 01/10/2007 | EP1740595A1 Polycyclic macrolactones |
| 01/10/2007 | EP1740577A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/10/2007 | EP1740551A1 Heterocyclic amide compound and use thereof as an mmp-13 inhibitor |
| 01/10/2007 | EP1658294B1 3h-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 01/10/2007 | EP1345945B1 Streptogramin derivatives, preparation thereof and compositions containing same |
| 01/10/2007 | CN1894260A Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 01/10/2007 | CN1894259A Rifamycin analogs and uses thereof |
| 01/10/2007 | CN1894258A Compositions useful as inhibitors of protein kinases |
| 01/10/2007 | CN1894238A Diamine derivatives |
| 01/10/2007 | CN1893953A Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists |
| 01/10/2007 | CN1893944A 3-cyano-quinoline derivatives with antiproliferative activity |
| 01/09/2007 | US7161010 Methine dyes; coloring compound |
| 01/09/2007 | US7160936 P-Bis(4-(oxo)-4H-3,1-benzazin-2-yl)benzene by imino-esterification of isatoic anhydride and terephthaloyl chloride in solvent and alkalie; heat resistance, storage stability, radiation transparent, films, moldings |
| 01/09/2007 | US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/09/2007 | US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors |
| 01/09/2007 | US7160888 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-[1,8]naphthyridin-2-one; use in the treatment of central nervous system disorders, bipolar disorder in a human |
| 01/09/2007 | US7160867 Rapamycin carbohydrate derivatives |
| 01/09/2007 | CA2196271C Quinolone- or naphthyridonecarboxylic acid derivative or salt thereof |
| 01/04/2007 | WO2007000432A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/04/2007 | WO2006110917A3 Spiro-oxindole compounds and their uses as therapeutic agents |
| 01/04/2007 | WO2006106423A3 Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
| 01/04/2007 | US20070004770 Preventive agent/remedial agent for constipation predominant IBS |
| 01/04/2007 | US20070004714 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 01/04/2007 | US20070004710 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 01/04/2007 | US20070004709 excitatory amino acid receptors modulators; for the treatment or prevention of disorders of memory and cognition; 6-chloro-4-ethyl-3,4-dihydro-2H-thieno[3,2-e][1,2,4]thiadiazine 1,1-dioxide; anxiety; depression; progressive neurodegenerative diseases |
| 01/04/2007 | US20070004706 New polymorphs of olanzapine hydrochloride |
| 01/04/2007 | CA2613874A1 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one compounds and the use thereof for producing drugs |
| 01/04/2007 | CA2612969A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/03/2007 | EP1737869A1 Regiospecific synthesis of rapamycin 42-ester derivatives |
| 01/03/2007 | EP1737864A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/03/2007 | EP1737841A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
| 01/03/2007 | EP1668012A4 Method for preparing cucurbiturils |
| 01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 01/03/2007 | EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 01/03/2007 | CN1293081C 28-epirapalogs, preparation method, medicament composition and use |
| 01/03/2007 | CN1293057C Ethylenediamine derivatives |
| 01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 01/02/2007 | US7157456 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 01/02/2007 | US7157447 Useful for treating HIV infection and AIDS |
| 01/02/2007 | CA2315909C Novel acronycine derivatives, preparation method and pharmaceutical compositions |
| 01/02/2007 | CA2177602C N-substituted azabicycloalkane derivatives, their preparation and use |
| 12/28/2006 | WO2006138192A1 Aspartyl protease inhibitors |
| 12/28/2006 | WO2006137772A1 New physical form of n,n´- disubstituted oxabispidines |
| 12/28/2006 | WO2006137771A1 Process for the preparation of sulfonic acid salts of oxabispidines |
| 12/28/2006 | WO2006137770A1 Process for the preparation of n,n´- disubstituted oxabispidines |
| 12/28/2006 | WO2006137769A1 Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes |
| 12/28/2006 | WO2006137258A1 Pharmaceutical composition comprising azarhodacyanine compound as active ingredient |
| 12/28/2006 | WO2006107273A8 Compounds having progestogenic activity and their use |
| 12/28/2006 | US20060293322 For therapy of lung and breast cancer |
| 12/28/2006 | US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 12/28/2006 | DE102005030051A1 New substituted 1-oxo-3,8-diazospiro(4.5)-decan-2-one compounds are 5-hydroxy tryptamine uptake receptor inhibitors, useful to treat and/or prevent e.g. pain, migraine, chronic paroxysomal hemicrania, depression and asthma |
| 12/28/2006 | CA2610812A1 Aspartyl protease inhibitors |
| 12/28/2006 | CA2610204A1 Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes |
| 12/28/2006 | CA2610093A1 Process for the preparation of sulfonic acid salts of oxabispidines |
| 12/28/2006 | CA2610089A1 Process for the preparation of n,n´- disubstituted oxabispidines |
| 12/27/2006 | EP1736471A1 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines |
| 12/27/2006 | EP1735321A1 Process for preparing rapamycin 42-esters and fk-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies |
| 12/27/2006 | EP1735308A1 Fused ring azadecalin glucocorticoid receptor modulators |
| 12/27/2006 | EP1597260B1 Triazole compounds useful in therapy |
| 12/27/2006 | EP1392870A4 Screening for enzyme inhibitors |
| 12/27/2006 | EP1173255B1 Use of pirenoxine for the protection of corneal tissues in photokeratectomy |
| 12/27/2006 | CN1886408A Polymorphous forms of rifaximin, processes for production and use in medicinal preparations |
| 12/27/2006 | CN1886407A Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 12/27/2006 | CN1884283A Chiral 3,4-disubstituted-2,5-bis[2'-(4'íó4'- disubstituted -5'íó5'- disubstitutedoxazolinyl)]furan compound and its synthesis method and uses |
| 12/26/2006 | US7153971 Contacting a carbohydrate with an amine to produce amino tetrahydroxy carbohydrate, protecting two hydroxy groups of tetrahydroxy carbohydrate, forming hydroxy heterocyclic-spiro moiety by reacting with activated carbonate, oxidizing OH |
| 12/26/2006 | US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 12/26/2006 | US7153957 Acylating a rapamycin 31-silyl ether to give a 42-ester boronate 31-silyl ether of rapamycin; selectively hydrolyzing the 42-ester boronate 31-silyl ether in mild acidic conditions to provide a rapamycin 42-ester boronate; treating rapamycin 42-ester boronate with a diol to provide 42-ester of rapamycin |
| 12/26/2006 | US7153882 (Aminocarbonyloxy)-benzofused ring derivatives; Alzheimer*s disease; neurodegenerative disorders |
| 12/26/2006 | US7153862 αv integrin receptor antagonists |
| 12/26/2006 | US7153851 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium |
| 12/26/2006 | US7153850 Lactam compounds and pharmaceutical use thereof |
| 12/26/2006 | US7153849 5HT1A antagonist; obsessive-compulsive disorder, panic attacks, generalized anxiety disorder, and social anxiety disorder |
| 12/21/2006 | WO2006135316A1 New oxabispidine compounds for the treatment of cardiac arrhythmias |
| 12/21/2006 | WO2006134378A1 Compounds for the treatment of multi-drug resistant bacterial infections |
| 12/21/2006 | US20060287371 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents |
| 12/21/2006 | US20060287356 Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
| 12/21/2006 | US20060287355 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 12/21/2006 | US20060287353 Method for preventing or treating ischemia-or hemorrhage-induced brain damage using a macrolide compound |
| 12/21/2006 | US20060287321 Novel Lactam Derivatives |
| 12/21/2006 | US20060287310 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-[1,8]naphthyridin-2-one; use in the treatment of central nervous system disorders, bipolar disorder in a human; chemical synthesis |
| 12/21/2006 | US20060287309 [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| 12/21/2006 | US20060287308 3-Aminoquinazolin-2,4-dione antibacterial agents |